| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.23 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.05 |